Product Information

FONDAPARINUX 7.5 MG/0.6 ML SYR is a generic product labeled by Mylan Institutional LLC, priced at $42.9123 per ML under NDC 67457058406. Its NADAC has been published 536 times since May 20, 2015.

FONDAPARINUX 7.5 MG/0.6 ML SYR

fondaparinux sodium
$42.9123per ML

Strength

7.5 mg/.6mL

NDC

67457058406

Classification

Generic

Dosage Form

INJECTION, SOLUTION

Route

SUBCUTANEOUS

Last Updated

6/17/2026

Active Ingredients

FONDAPARINUX SODIUM

Approval Type

Authorized Generic (NDA)

FDA Application

NDA021345

On Market Since

1/5/2015

Pharmacological Classes

Factor Xa Inhibitor
Factor Xa Inhibitors

Price Statistics

The NADAC for FONDAPARINUX 7.5 MG/0.6 ML SYR has been published 536 times since May 20, 2015, and over the history we have for it it has declined 66.9%. The table below summarizes its recorded NADAC range and movement.

Current price$42.9123 per ML
All-time high$129.7260 (Jun 10, 2015)
All-time low$34.9283 (Jun 19, 2024)
52-week high$43.4533
52-week low$38.4841
Median price$67.7570
Average price$68.9631
Largest weekly change-30.5% (Jul 20, 2016)
Weeks tracked536
Tracking sinceMay 20, 2015

Price History

1W

0.0%

1M

-1.1%

3M

+0.1%

6M

+6.9%

1Y

+11.5%

3Y

-25.3%

5Y

-37.5%

All

-66.9%

Generic Alternatives

The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 51% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of FONDAPARINUX 7.5 MG/0.6 ML SYR?

The current National Average Drug Acquisition Cost (NADAC) for FONDAPARINUX 7.5 MG/0.6 ML SYR, manufactured by Mylan Institutional LLC, is $42.9123 per ML (NDC 67457058406), effective Jun 24, 2026.

How has the price of FONDAPARINUX 7.5 MG/0.6 ML SYR changed over time?

Over the history we have for it, the NADAC for FONDAPARINUX 7.5 MG/0.6 ML SYR has declined 66.9%. It has been tracked across 536 weekly CMS publications since May 20, 2015.

What are the highest and lowest recorded NADAC prices for FONDAPARINUX 7.5 MG/0.6 ML SYR?

Since May 20, 2015, the NADAC for FONDAPARINUX 7.5 MG/0.6 ML SYR has ranged from a low of $34.9283 (Jun 19, 2024) to a high of $129.7260 (Jun 10, 2015), with a median of $67.7570 per ML.

Are there cheaper alternatives to FONDAPARINUX 7.5 MG/0.6 ML SYR?

Yes. 1 NADAC-published product shares the same active ingredient, strength, and dosage form. The lowest-priced option, FONDAPARINUX 7.5 MG/0.6 ML SYR, is $20.9233 per ML — about 51% below FONDAPARINUX 7.5 MG/0.6 ML SYR.

Who manufactures FONDAPARINUX 7.5 MG/0.6 ML SYR?

FONDAPARINUX 7.5 MG/0.6 ML SYR (NDC 67457058406) is labeled by Mylan Institutional LLC, and CMS classifies it as a generic product.